Citations are updated once a week. Recently added citations may not appear.
The suggestion is based on each study and bacteria having different weight based on a multitude of factors. For example, how severe a shift is seen.
| Context | Citation |
|---|---|
| Increases Xylanibacter ruminicola - : Ganoderma sichuanense {Reishi Mushroom} |
👶
Polysaccharides of Sporoderm-Broken Spore of Ganoderma lucidum Modulate Adaptive Immune Function via Gut Microbiota Regulation. Evidence-based complementary and alternative medicine : eCAM (Evid Based Complement Alternat Med ) Vol: 2021 Issue Pages: 8842062 Pub: 2021 Epub: 2021 Mar 23 Authors Su L , Li D , Su J , Zhang E , Chen S , Zheng C , Luo T , Li M , Chen X , Huang G , Xie Y , Li S , Html Article Publication |
| Increases Xylanibacter ruminicola - : Ganoderma sichuanense {Reishi Mushroom} |
👶
Regulatory effect of Ganoderma lucidum and its active components on gut flora in diseases. Frontiers in microbiology (Front Microbiol ) Vol: 15 Issue Pages: 1362479 Pub: 2024 Epub: 2024 Mar 18 Authors Qin X , Fang Z , Zhang J , Zhao W , Zheng N , Wang X , Html Article Publication |
| Increases Xylanibacter ruminicola - : Ganoderma sichuanense {Reishi Mushroom} |
👶
Effects of Mexican Ganoderma lucidum extracts on liver, kidney, and the gut microbiota of Wistar rats: A repeated dose oral toxicity study. PloS one (PLoS One ) Vol: 18 Issue 4 Pages: e0283605 Pub: 2023 Epub: 2023 Apr 6 Authors Meneses ME , Martínez-Carrera D , González-Ibáñez L , Torres N , Sánchez-Tapia M , Márquez-Mota CC , Rendón G , Mitzi V , Morales A , Tello-Salgado I , Tovar AR , Html Article Publication |
| 0 😁 | 😢 0 |
Explanations /Info /Descriptions are influenced by Large Language Models and may not be accurate and include some hallucinations.Please report any to us for correction.
Copyright 2016 - 2025 Lassesen Consulting, LLC[2007], DBA, Microbiome Prescription All rights served. Permission to data scrap or reverse engineer is explicitly denied to all users.U.S.Code Title 18 PART I CHAPTER 47 § 1030, CETS No.185, CFAA Use of data on this site is prohibited except under written license.There is no charge for individual personal use.Use for any commercial applications or research requires a written license. Caveat emptor: Analysis and suggestions are based on modelling(and thus infererence ) based on studies.The data sources are usually given for those that wish to consider alternative inferences.theories and models. Inventions /Methodologies on this site are Patent Pending.
Microbiome Prescription do not make any representations that data or analyses available on this site is suitable for human diagnostic purposes, for informing treatment decisions,
or for any other purposes and accept no responsibility or liability whatsoever for such use.
This site is not in strict compliance with Personal Health Information Laws. [216.73.216 ]
